Trials / Conditions / Relapsed Primary Central Nervous System Lymphoma
Relapsed Primary Central Nervous System Lymphoma
3 registered clinical trials studyying Relapsed Primary Central Nervous System Lymphoma — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | A Study of Epcoritamab and Ibrutinib in People With Central Nervous System Lymphoma (CNSL) NCT07082868 | Memorial Sloan Kettering Cancer Center | Phase 1 |
| Unknown | A Case Study of Nivolumab for Relapsed/Refractory Primary Central Nervous System Lymphoma NCT04845139 | Second Affiliated Hospital, School of Medicine, Zhejiang University | N/A |
| Recruiting | CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractor NCT03328078 | Curis, Inc. | Phase 1 / Phase 2 |